Results 1 to 10 of about 26,002 (208)
ABSTRACT Primary parvovirus B19 infection is an infrequent, but serious and treatable, cause of chronic anemia in immunocompromised hosts. Many compromised hosts have preexisting antibody to B19 and are not at risk. However, upon primary infection, some patients may be able to mount a sufficient immune response to terminate active parvovirus ...
Marie Louise Landry
core +5 more sources
Acute parvovirus B19 infection associated with multi-organ involvement in an immunocompetent adult [PDF]
Introduction: Human parvovirus B19 is a highly prevalent single-stranded deoxyribonucleic acid virus that infects a large proportion of the global population.
Akshaye Gopaul +2 more
doaj +2 more sources
Background Human parvovirus B19 (B19V) is responsible of a wide clinical spectrum ranging from asymptomatic infection, through mild disease, up to life threatening one. Outbreaks are registered every three to four years and a recent international alert for a new outbreak has been released.
Ranno S +14 more
europepmc +3 more sources
Background: Parvovirus B19 is a human pathogenic virus associated with a wide range of clinical conditions. During pregnancy congenital infection with parvovirus B19 can be associated with poor outcome, including miscarriage, fetal anemia and non-immune
Tagwa Hafiz Abdelkabeer +4 more
doaj +1 more source
Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis
Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear.
Charat Thongprayoon +13 more
doaj +1 more source
SUMMARYParvovirus B19(B19) was discovered in 1974 and is the only member of the familyParvoviridaeknown to be pathogenic in humans. Despite the inability to propagate the virus in cell cultures, much has been learned about the pathophysiology of this virus, including the identification of the cellular receptor (P antigen), and the control of the virus ...
Erik D, Heegaard, Kevin E, Brown
openaire +2 more sources
INTRODUCTION[|]Parvovirus B19 belonging to the Erythrovirus genus is a single-stranded DNA virus in the family Parvoviridae. The present study aims to determine parvovirus B19 seropositivity in serum samples sent with pre-diagnosis of arthritis ...
Hilal Türkmen Albayrak +3 more
doaj +1 more source
Immunosuppressed patients can contract parvovirus B19, and some may experience hemophagocytic lymphohistiocytosis (HLH). Herein, we describe the first report of hemophagocytic lymphohistiocytosis in a heart-lung transplant patient with concomitant ...
Xuewu Zhang +11 more
doaj +1 more source
Background: The immunosuppressive drug therapy makes post-transplant recipients are at risk of developing both primary viral diseases and reactivation of persistent viruses.
K.D.S.T. Abeywardana, S.N. Janage
doaj +1 more source
Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients
Introduction: Parvovirus B19 is a cause of hemolysis and red blood cell aplasia in patients with sickle cell anemia. The present study aimed to assess parvovirus B19 infection among sickle cell anemia patients.
Obeid E Obeid
doaj +1 more source

